Nano Tech

Despite encouraging midstage data for AstraZeneca’s drug for systemic lupus erythematosus (SLE), anifrolumab has missed the target in the first of two ongoing…

RootPath, the brainchild of scientists and bioengineers from MIT, Harvard, Stanford and the like, has raised $7 million in seed funding to develop a T-cell…

Pfizer halted two ongoing phase 2 trials of its Duchenne muscular dystrophy drug domagrozumab after the main efficacy study failed to meet its primary endpoint…

A team of researchers have discovered that terahertz (THz) wave irradiation activates the filamentation of actin protein. Drs. Shota Yamazaki and Masahiko…

Scientists have determined the DNA code of the opium poppy genome, uncovering key steps in how the plant evolved to produce the pharmaceutical compounds…

August marks National Immunization Awareness Month – a time to take inventory on where we stand, and recognize how far we’ve come, in advancing breakthrough…

Some cancer cells initially respond well to drug treatments, but then become resistant and start growing again. Others simply grow so fast drug treatments…

China’s Jacobio Pharmaceuticals has raised $55 million in series C funding to advance an oncology asset into the clinic, conduct preclinical work and ramp up…

Roche Diagnostics aims to build its own talent pipeline for medtech specialists through the University of Indianapolis and the newly created Roche Academy,…

Arvinas has been on a roll this year, starting with a Pfizer R&D deal worth potentially $830 million and bagging a $55 million series C in April to push…